These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. How to integrate serum tumor markers into clinical oncologic practice. van Dalen A Nutrition; 1995; 11(5 Suppl):489-91. PubMed ID: 8748205 [TBL] [Abstract][Full Text] [Related]
23. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer. Jiang XT; Tao HQ; Zou SC Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690 [TBL] [Abstract][Full Text] [Related]
24. [Tumor markers. Their current diagnostic status]. Kudlacek S Wien Med Wochenschr; 1988 May; 138(10):228-42. PubMed ID: 3043919 [TBL] [Abstract][Full Text] [Related]
25. [Tumor markers as a means of cancer diagnosis--expectations and problems]. von Broen B Z Gesamte Inn Med; 1987 Jul; 42(14):377-82. PubMed ID: 3314200 [TBL] [Abstract][Full Text] [Related]
26. Cancer Drug Development: New Targets for Cancer Treatment. Curt GA Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987 [TBL] [Abstract][Full Text] [Related]
27. [Biomarker in gynecologic malignancies]. Isonishi S Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576 [TBL] [Abstract][Full Text] [Related]
28. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
32. Methylation profiling of human cancers in blood: molecular monitoring and prognostication (review). Wong IH Int J Oncol; 2001 Dec; 19(6):1319-24. PubMed ID: 11713606 [TBL] [Abstract][Full Text] [Related]
33. [Diagnostic significance of tumor markers for gynecologic malignancies]. Aoki D; Hirasawa A; Susumu N Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829 [TBL] [Abstract][Full Text] [Related]
34. [Blood tumor markers in patients with lung cancer]. Bianco A; Marcatili P; D'Auria D; Sorrentino P; Zofra S Ann Ital Med Int; 1996; 11(2):114-8. PubMed ID: 8974436 [TBL] [Abstract][Full Text] [Related]
35. Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer. Okusaka T; Okada S; Sato T; Wakasugi H; Saisho H; Furuse J; Ishikawa O; Matsuno S; Yokoyama S Hepatogastroenterology; 1998; 45(21):867-72. PubMed ID: 9684148 [TBL] [Abstract][Full Text] [Related]
36. Cell surface carbohydrates as prognostic markers in human carcinomas. Dabelsteen E J Pathol; 1996 Aug; 179(4):358-69. PubMed ID: 8869281 [TBL] [Abstract][Full Text] [Related]
37. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors. Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610 [TBL] [Abstract][Full Text] [Related]
38. Tumor markers in staging and prognosis of colorectal carcinoma. Levy M; Visokai V; Lipska L; Topolcan O Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252 [TBL] [Abstract][Full Text] [Related]
39. Blood biomarkers for prostate cancer detection and prognosis. Shariat SF; Karam JA; Roehrborn CG Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720 [TBL] [Abstract][Full Text] [Related]
40. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer. Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]